ACCESSWIRE
24 Jan 2023, 21:05 GMT+10
ORLANDO, FL / ACCESSWIRE / January 24, 2023 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a pioneer in the science of using novel transdermal solutions and other innovative technologies, today announced details of the Company's participation at the 2023 Transdermal and Microneedle Conference taking place January 23-24, 2023, at the Copthorne Tara Hotel, London, United Kingdom.
Gareth Sheridan, Nutriband's CEO, will give a presentation at 11:00 a.m. GMT on January 24th entitled ‘Improving existing transdermal technologies to reduce the liability profile of abusable medications' which will provide an overview of the development of transdermal drug delivery systems using Nutriband's AVERSA technology as a reference point.
Nutriband COO and President of its 4P Therapeutics subsidiary, Dr. Alan Smith, will participate in a panel discussion at 11:40 a.m. GMT on January 24th on the topic of microneedles as a therapeutic tool. The panel will be moderated by James Birchall, Professor of Pharmaceutical Sciences, Cardiff University.
An overview of the panel discussion is as follows:
Reviewing microneedles technologies as a novel therapeutic tool for drug delivery
Conference presentations and panelists are also expected from Merck (NYSE: MRK), GSK (NYSE: GSK), Sanofi (NASDAQ: SNY), Rani Therapeutics (NASDAQ: RANI), Leo Pharmaceuticals, Vaxxas and Starton Therapeutics.
About AVERSA™ Technology
AVERSA™ abuse deterrent transdermal technology incorporates aversive agents to prevent the Abuse, DiVERsion, MiSuse and Accidental exposure of drugs with abuse potential specifically Opioids. Our first application for AVERSA is for our abuse deterrent fentanyl transdermal patch which we are developing to provide clinicians and patients with an extended release chronic pain relief. The goal is to make these pain treatments safe for all who need them. When used correctly they provide incredible relief and care to chronic pain patients.
About Nutriband Inc.
We are primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Our lead product under development is an abuse deterrent fentanyl patch incorporating our AVERSA™ abuse deterrence technology. AVERSA™ technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.
The Company's website is www.nutriband.com. Any material contained in or derived from the Company's websites or any other website is not part of this press release.
Forward-Looking Statements
This communication contains 'forward-looking statements.' Such statements may be preceded by the words 'intends,' 'may,' 'will,' 'plans,' 'expects,' 'anticipates,' 'projects,' 'predicts,' 'estimates,' 'aims,' 'believes,' 'hopes,' 'potential,' or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified, and, consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) difficulties in obtaining financing on commercially reasonable terms; (ii) changes in the size and nature of our competition; (iii) loss of one or more key executives or brand ambassadors; and (iv) changes in legal or regulatory requirements in the markets in which we operate. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.
For more information, contact:
Investor Relations
RedChip Companies
Dave Gentry
NTRB@redchip.com
1-800-RED-CHIP (733-2447)
407-491-4498
SOURCE: Nutriband Inc.
Get a daily dose of Raleigh Times news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Raleigh Times.
More InformationTOKYO, Japan: Japan is preparing to revise legislation to allow it to restrict the export of advanced semiconductor manufacturing equipment ...
LONDON, England: Energy giant Shell Oil has announced a record profit of nearly $40 billion in 2022, capping an eventful ...
TOKYO, Japan: Honda has announced that it will manufacture a new hydrogen fuel cell system, which was jointly developed with ...
IRVINE, California: In an effort to cut costs in preparation for an industry-wide price war, electric vehicle manufacturer Rivian Automotive, ...
SANTA CLARA, California: One week after Intel forecasted lower-than-expected sales caused by a loss of market share to rivals and ...
WASHINGTON D.C.: As part of a wider policy drive to increase competition in consumer markets, President Joe Biden has announced ...
CHICAGO, Illinois: After an ice storm ravaged states from Texas to West Virginia, this week, airlines canceled over 1,800 flights ...
WASHINGTON D.C.: The US House of Representatives has passed a bill that limits the ability of US Energy Secretary Jennifer ...
Double-doubles by Paolo Banchero and Wendell Carter Jr. carried the Orlando Magic to a 119-113 victory against the host Charlotte ...
No. 23 Miami and unranked Duke have little time to celebrate after picking up key Atlantic Coast Conference wins over ...
Dereck Lively's basket off an offensive rebound with 1:45 to play broke a tie and Duke's defense did the rest ...
Washington [US], February 5 (ANI): The United States has shot down a Chinese spy balloon over the Atlantic Ocean, CNN ...